- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Net Ingredient Cost of antidiabetic drugs in England 2015/16, by type
Net Ingredient Cost of antidiabetic drugs in England 2015/16, by type
Net Ingredient Cost (NIC) of antidiabetic drugs (other than biguanides and sulfonylureas) in England in 2015/16 (in 1,000 GBP)
This statistic displays the Net Ingredient Cost (NIC) of antidiabetic drugs other than biguanides and sulfonylureas in England in 2015/16. In this year, the leading other antidiabetic drug in terms of net ingredient cost was Sitagliptin, costing approximately 93.7 million British pounds.
Net Ingredient Cost (NIC) of antidiabetic drugs (other than biguanides and sulfonylureas) in England in 2015/16 (in 1,000 GBP)
Loading statistic...
Expand statistic
| Net Ingredient Cost in thousand GBP | |
|---|---|
| Sitagliptin* | 93,690.6 |
| Pioglitazone Hydrochloride* | 17,320.7 |
| Linagliptin* | 31,389.9 |
| Liraglutide** | 47,577.3 |
| Saxagliptin* | 12,089.2 |
| Dapagliflozin* | 23,312.8 |
| Exenatide | 19,362.4 |
| Vildagliptin* | 5,219.1 |
| Repaglinide | 626.7 |
| Lixisenatide | 5,792.9 |
| Acarbose | 523.8 |
| Canagliflozin* | 7,944.6 |
| Alogliptin* | 4,772.7 |
| Nateglinide | 355.1 |
| Empagliflozin* | 1,900.9 |
| Dulaglutide | 693.5 |
| Rosiglitazone* | 0.2 |
| Net Ingredient Cost in thousand GBP | |
|---|---|
| Sitagliptin* | 93,690.6 |
| Pioglitazone Hydrochloride* | 17,320.7 |
| Linagliptin* | 31,389.9 |
| Liraglutide** | 47,577.3 |
| Saxagliptin* | 12,089.2 |
| Dapagliflozin* | 23,312.8 |
| Exenatide | 19,362.4 |
| Vildagliptin* | 5,219.1 |
| Repaglinide | 626.7 |
| Lixisenatide | 5,792.9 |
| Acarbose | 523.8 |
| Canagliflozin* | 7,944.6 |
| Alogliptin* | 4,772.7 |
| Nateglinide | 355.1 |
| Empagliflozin* | 1,900.9 |
| Dulaglutide | 693.5 |
| Rosiglitazone* | 0.2 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic displays the Net Ingredient Cost (NIC) of antidiabetic drugs other than biguanides and sulfonylureas in England in 2015/16. In this year, the leading other antidiabetic drug in terms of net ingredient cost was Sitagliptin, costing approximately 93.7 million British pounds.
Show more- Show sources information
- Show publisher information
- Release date
- August 2016
- Region
- United Kingdom (England)
- Survey time period
- April 2005 to March 2016
- Supplementary notes
-
* includes combination with metformin.
** includes combination with insulin degludec.
The source also adds the following information: "Please note where drugs are shown to include combinations with metformin this is only where a combination product containing both drugs has been prescribed. There is no information on whether the combination of metformin and another Other antidiabetic drug is prescribed separately as patient information is not captured within the dataset."
Source
- Show sources information
- Show publisher information
- Release date
- August 2016
More information
- Region
- United Kingdom (England)
- Survey time period
- April 2005 to March 2016
- Supplementary notes
-
* includes combination with metformin.
** includes combination with insulin degludec.
The source also adds the following information: "Please note where drugs are shown to include combinations with metformin this is only where a combination product containing both drugs has been prescribed. There is no information on whether the combination of metformin and another Other antidiabetic drug is prescribed separately as patient information is not captured within the dataset."
Other statistics on the topic
Diabetes in the United Kingdom
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Diabetes in the United Kingdom (UK)
- 87 page/s
- English
- pptx
- Detailed references
Everything On "Diabetes in the United Kingdom (UK)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Diabetes in the United Kingdom (UK)"
- Individuals registered with diabetes
The most important statistics
- Share of people with diabetes in the United Kingdom (UK) in 2016, by countryPrevalence of diabetes in the United Kingdom (UK) 2016
- Proportion of people registered with diabetes in England in 2017 by gender*England: share of people with diabetes 2017, by gender
- Percentage of people registered with type 1 diabetes in England in 2017, by age*England: share of people with type 1 diabetes 2017, by age
- Share of people registered with type 2 diabetes in England from 2016 to 2017, by age*England: share of individuals with type 2 diabetes 2016-2017, by age
- Share of individuals registered with diabetes in England from 2016 to 2017, by ethnicity*England: share of people with diabetes 2016-2017, by ethnicity
- Share of people registered with diabetes in England from 2016-2017, by deprivation quintileEngland: share of people with diabetes 2016-2017, by deprivation quintile
- Number of individuals registered with diabetes in England and Wales from 2016 to 2017, by typeIndividuals with diabetes in England and Wales 2016-2017, by type
- Proportion of individuals with diabetes in Scotland from 2003 to 2016=7, by gender Share of adults with diabetes in Scotland 2003-2017, by gender
- Treatment available
The most important statistics
- Proportion of patients receiving care processes and treatment for diabetes in England and Wales in 2016/17, by typeEngland: share of patients receiving care processes for diabetes 2016/17, by type
- Proportion of patients receiving care processes and treatment for diabetes in Wales from 2016 to 2017, by typeWales: share of patients receiving care processes for diabetes 2016-2017, by type
- Proportion of individuals newly diagnosed with diabetes who were offered structured education in England from 2009/10 to 2014/15Education offered for individuals with diabetes in England 2009-2015
- Proportion of individuals newly diagnosed with diabetes offered structured education on diabetes in Wales in 2015Education offered for individuals with diabetes in Wales 2015
- Share of diabetics who self manage their insulin in England and Wales in 2015, by diabetes typeSelf management of insulin in England and Wales in 2015, by type
- Share of diabetics who self-tested their glucose levels in England and Wales in 2015, by diabetes typeDiabetics self-testing their glucose levels in England and Wales in 2015, by type
- Drugs and Devices Available
The most important statistics
- Leading ten drugs used in the treatment of diabetes in England in 2018, by number of itemsLeading ten drugs used for diabetes in England 2018, by items
- Total number of items for drugs used in diabetes in England from 2005/06 to 2017/18 (total items in millions)Total number of items for drugs used in diabetes in England 2005-2018
- Net ingredient cost for drugs used in diabetes in England from 2005/06 to 2017/18 (in million GBP)England: net ingredient cost for drugs used in diabetes 2005-2018
- Proportion of items in primary care prescribing accounted for by drugs for diabetes in England from 2005/06 to 2017/18England: proportion of items accounted for by drugs for diabetes 2005-2018
- Proportion of net ingredient cost accounted for by drugs for diabetes in England from 2005/06 to 2017/18England: share of net ingredient cost accounted for by drugs for diabetes 2005-2018
- Total number of insulin items prescribed for diabetes in England from 2005/06 to 2017/18 (in millions)England: number of insulin items prescribed for diabetes 2005-2018
- Total net ingredient cost (NIC) for insulins for diabetes in England from 2005/06 to 2017/18 (in millions GBP)England: net ingredient cost for insulins for diabetes 2005-2018
- Total number of human analogue insulins prescribed in England from 2005/06 to 2017/18 (in millions)England: total number of human analogue insulins prescribed 2005-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Antidiabetic combinations per 1,000 inhabitants per day in Spain 2014, by type
- Dipeptidyl peptidase-4 consumption per 1,000 inhabitants per day Spain 2014, by type
- Pioglitazone consumption per 1,000 inhabitants per day in Spain 2010-2014
- Sulfonylureas consumption per 1,000 inhabitants per day in Spain 2014, by type
- Alpha-glucosidase inhibitors consumption per 1,000 inhabitants per day in Spain 2014
- Antidiabetic consumption per 1,000 inhabitants per day Spain 2014, by type
- Sales value of drugs used in diabetes in Spain 2004-2015
- Inpatients with diabetes in England and Wales 2013, by type
- Rate of people treated for diabetes in France 2014, by gender
- Rate of people treated for diabetes in France 2015, by region
- Rate of people treated for diabetes in France 2015, by age
- Share of adults with diabetes in England 2013, by gender and waist circumference
- Number of people treated for diabetes in France 2015, by gender
- Diabetes among adults in Texas as of 2017, by income level
- Users of eHealth solutions for Heart Failure forecast by subsegment in the United Kingdom...
- Mexico: number of diabetes cases in 2017
- Lead, zinc and tin production revenue in France 2011-2023
- Import value of ultrasonic scanning apparatus in the UK 2011-2017
Studies
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Prescribing for Diabetes, England 2007/08 to 2017/18
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Prescribed Drug Spending in Canada, 2018
- Drug Use Among Seniors in Canada, 2016
- Antibiotic use in the United Kingdom (UK)
- Prescribed Drug Spending in Canada, 2017
- Prescribing for Diabetes, England 2005/06 to 2015/16
- Prescription drug access and affordability an issue for nearly a quarter of all Canadian h...
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- Prescription Cost Analysis, England 2014
- Prescription Cost Analysis, England 2015
- Prescribing by dentists, England 2013
- Meds Entry Watch 2017
- Prescribed Drug Spending in Canada, 2013
Statistics on "Diabetes in the United Kingdom (UK)"
- Share of people with diabetes in the United Kingdom (UK) in 2016, by country
- Proportion of people registered with diabetes in England in 2017 by gender*
- Percentage of people registered with type 1 diabetes in England in 2017, by age*
- Share of people registered with type 2 diabetes in England from 2016 to 2017, by age*
- Share of individuals registered with diabetes in England from 2016 to 2017, by ethnicity*
- Share of people registered with diabetes in England from 2016-2017, by deprivation quintile
- Number of individuals registered with diabetes in England and Wales from 2016 to 2017, by type
- Proportion of individuals with diabetes in Scotland from 2003 to 2016=7, by gender
- Distribution of reasons why diabetics were admitted to hospital in England and Wales in 2015
- Proportion of patients receiving care processes and treatment for diabetes in England and Wales in 2016/17, by type
- Proportion of patients receiving care processes and treatment for diabetes in Wales from 2016 to 2017, by type
- Proportion of individuals newly diagnosed with diabetes who were offered structured education in England from 2009/10 to 2014/15
- Proportion of individuals newly diagnosed with diabetes offered structured education on diabetes in Wales in 2015
- Share of diabetics who self manage their insulin in England and Wales in 2015, by diabetes type
- Share of diabetics who self-tested their glucose levels in England and Wales in 2015, by diabetes type
- Leading ten drugs used in the treatment of diabetes in England in 2018, by number of items
- Total number of items for drugs used in diabetes in England from 2005/06 to 2017/18 (total items in millions)
- Net ingredient cost for drugs used in diabetes in England from 2005/06 to 2017/18 (in million GBP)
- Proportion of items in primary care prescribing accounted for by drugs for diabetes in England from 2005/06 to 2017/18
- Proportion of net ingredient cost accounted for by drugs for diabetes in England from 2005/06 to 2017/18
- Total number of insulin items prescribed for diabetes in England from 2005/06 to 2017/18 (in millions)
- Total net ingredient cost (NIC) for insulins for diabetes in England from 2005/06 to 2017/18 (in millions GBP)
- Total number of human analogue insulins prescribed in England from 2005/06 to 2017/18 (in millions)
- Total net ingredient cost (NIC) of human analogue insulins in England from 2005/06 to 2017/18 (in million GBP)
- Total number of items prescribed of short-acting insulins in England from 2005/06 to 2017/18 (in millions)
- Net ingredient cost (NIC) for intermediate and long-acting insulins in England from 2005/06 to 2017/18 (in million GBP)
- Net ingredient cost (NIC) for short-acting insulins in England from 2005/06 to 2017/18 (in million GBP)
- Total number of items prescribed of intermediate and long-acting insulins in England from 2005/06 to 2017/18 (in millions)
- Total number of items prescribed of antidiabetic drugs in England from 2005/06 to 2017/18 (in millions)
- Net ingredient cost (NIC) for antidiabetic drugs in England from 2005/06 to 2017/18 (in million GBP)
- Net Ingredient Cost (NIC) of blood glucose monitoring items in England from 2005/06 to 2015/16 (in million GBP)
- Total number of items prescribed of antidiabetic drugs in England in 2015/16, by type of drug (in 1,000)
- Net ingredient cost (NIC) of sulfonylureas in England from 2005/06 to 2017/18 (in million GBP)
- Total number of items prescribed of sulfonylureas antidiabetic drugs in England from 2005/06 to 2017/18 (in millions)
- Total number of items prescribed of biguanides antidiabetic drugs in England from 2005/06 to 2017/18 (in millions)
- Net ingredient cost (NIC) of biguanides antidiabetic drugs in England from 2005/06 to 2017/18 (in million GBP)
- Net Ingredient Cost (NIC) of antidiabetic drugs (other than biguanides and sulfonylureas) in England in 2015/16 (in 1,000 GBP)
- Cost per item of antidiabetic drugs (other than biguanides and sulfonylureas) in England in 2015/16 ( Cost in GBP)
- Number of blood glucose monitoring items in England from 2005/06 to 2015/16 (in millions)
- Defined daily dose of antidiabetic combinations per 1,000 inhabitants per day in Spain in 2014, by type
- Defined daily dose of dipeptidyl peptidase-4 (DPP4) per 1,000 inhabitants per day in Spain in 2014, by type
- Defined daily dose of pioglitazone per 1,000 inhabitants per day in Spain from 2010 to 2014
- Defined daily dose of antidiabetic sulfonylurea drugs per 1,000 inhabitants per day in Spain in 2014, by type
- Defined daily dose of alpha-glucosidase inhibitors per 1,000 inhabitants per day in Spain in 2014, by type
- Defined daily dose of antidiabetics per 1,000 inhabitants per day in Spain in 2014, by type
- Total sales value of drugs used in diabetes in Spain from 2004 to 2015 (in million euros)
- Share of inpatients with diabetes in England and Wales in 2013, by type
- Number of people treated for diabetes per 1,000 people in France in 2014, by gender
- Number of people treated for diabetes per 1,000 people in France in 2015, by region
- Number of Diabetes Health Insurance coverage per 1,000 people in France in 2015, by age group
- Proportion of individuals who have diabetes in England in 2013, by gender and waist circumference
- Number of people treated for diabetes in France in 2015, by gender
- Percentage of adults in Texas who reported being told by a health professional that they had diabetes as of 2017, by income level
- Users of eHealth solutions for Heart Failure forecast by subsegment in the United Kingdom from 2016 to 2022 (in thousands)
- Number of people with diabetes in Mexico in 2017 (in millions)
- Lead, zinc and tin production revenue in France from 2011 to 2023 (in million U.S. Dollars)
- Import value of ultrasonic scanning apparatus in the United Kingdom (UK) from 2011 to 2017 (in 1,000 GBP)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.